Regular article
Autoantibodies to histones and their subfractions in chronic liver diseases

https://doi.org/10.1016/0090-1229(89)90207-9Get rights and content

Abstract

Sera of 78 patients with different chronic liver diseases were examined for the presence of anti-histone activity using an enzyme-linked immunosorbent assay. Eighteen patients had primary biliary cirrhosis (PBC), 20 had chronic active hepatitis, and 40 had cirrhosis. Anti-histone antibodies were detected in 34 patients (43.6%), distributed among all liver disease entities studied. When antibodies of specific isotypes (IgG, IgM, and IgA) were measured, even higher frequencies were noted—50% for IgG and 53.8% for IgA. Antibodies to histone subfractions H1, H2a, H2b, H3, and H4 were also observed in all liver disorders investigated (in 22–32% of patients)—H1 and H3 being the prominent fractions involved. Of the various disease entities examined PBC was the one disclosing the highest frequency of anti-histone antibodies.

References (22)

  • A. Aitkaci et al.

    J. Immunol. Methods

    (1981)
  • F. Konikoff et al.

    Clin. Immunol. Immunopathol.

    (1987)
  • D.R. Van der Westhuyzen et al.

    FEBS Lett.

    (1971)
  • K. Weber et al.
  • Y. Shoenfeld et al.

    Clin. Immunol. Immunopathol.

    (1987)
  • I. Isenberg

    Annu. Rev. Biochem.

    (1979)
  • H.G. Kunkel et al.
  • M.J. Fritzler et al.

    J. Rheumatol.

    (1982)
  • O. Meyer et al.

    Rev. Rhum. Mal. Osteo-Articulaires

    (1984)
  • M.J. Fritzler et al.

    J. Clin. Invest.

    (1978)
  • H. Krippner et al.

    Clin. Exp. Immunol.

    (1984)
  • Cited by (27)

    • Gastrointestinal: Liver

      2011, Systemic Lupus Erythematosus
    • Nucleic acid-associated autoantigens: Pathogenic involvement and therapeutic potential

      2010, Journal of Autoimmunity
      Citation Excerpt :

      In particular, H2A-H2B dimers are frequently recognized by anti-histone Abs (AHA), especially in drug-induced LE [11,13,14]. AHA can be found in a variety of diseases, including inflammatory hepatic [15], malignant, infectious [16] and, of course, rheumatic autoimmune diseases [17] (Table 1). They may be present in up to 75% of SLE sera and in more than 90% of drug-induced lupus, while their prevalence in other rheumatic diseases usually does not exceed 20% [18,19].

    • Gastrointestinal: Liver

      2010, Systemic Lupus Erythematosus, Fifth Edition
    • Autoantibodies in Autoimmune Liver Disease

      2005, Advances in Clinical Chemistry
      Citation Excerpt :

      Antibodies to histones do not have established pathogenic effects, but their binding to the histones of the nucleosome could destabilize the nucleus and impair nuclear functions. The assay for anti‐histones is an EIA based on total histones (H1, H2A, H2B, H3, and H4) derived from calf thymus [48, 49, 227, 228]. Western blotting is required for separation of the histones and determination of the predominant individual reactivities [49].

    • Antihistone antibodies

      2004, Systemic Lupus Erythematosus, Fourth Edition
    View all citing articles on Scopus
    View full text